Article images may contain Chinese text.
On August 28–29, 2025, the 2025 Baidu Cloud Intelligence Conference was held at Phase II of the China National Convention Center in Beijing. As a specialist in AI-powered digital technologies and solutions for the pharmaceutical industry, Weiming Penguin founder & CEO Dr. Zou Xiaoliang was invited to important conference sessions, contributing in depth to the core AI + healthcare agenda and demonstrating Weiming Penguin’s influence in the healthcare AI sector.
Conference Schedule — Dr. Zou Xiaoliang Invited to AttendOn the evening of August 28, Dr. Zou Xiaoliang first attended the guest dinner, engaging in in-depth discussions with leading figures from across the industry ahead of the main sessions. On August 29, the conference focused on the AI + Healthcare Forum. Zou Xiaoliang participated throughout the core sessions, contributing ideas and recommendations for the development of the healthcare AI industry.Roundtable — New AI-Powered Scenarios in the Healthcare IndustryAt the roundtable, Weiming Penguin founder & CEO Dr. Zou Xiaoliang joined prominent guests for an in-depth discussion on “New AI-Powered Scenarios in the Healthcare Industry.” They included Wang Lihua, deputy director of the office of the Medical Digital Intelligence Innovation Center at Beijing Friendship Hospital; Zhang Xiaoliang, director of the Information Office at Jiangsu Province Hospital’s Suqian Hospital; Gao Xiaole, president of the Internet Hospital at the First Affiliated Hospital of Henan University of Science and Technology; Wu Zongxun, vice president of Fosun International and Fosun’s chief intelligent technology officer (CITO); Gao Liang, general manager of the Biocomputing Innovation and Development Platform at BioMap; and Yang Qing, general manager of the Healthcare Products Department at Baidu AI Cloud.Moderated by Bai Jianfeng—a senior reporter at People’s Daily, editor-in-chief in its Economic and Social Affairs Department, and member of China’s national health science popularization expert pool—the forum focused on core topics including “How AI and Big Data Can Empower the Pharmaceutical Industry” and “Expectations for the Development of Pharmaceutical Digitalization in the AI Era.” Drawing on Weiming Penguin’s practical experience in healthcare AI, Zou Xiaoliang shared his distinctive insights on industry advancement.3. Launch Ceremony — Baidu AI Cloud Smart Healthcare Partner AllianceAt the launch ceremony for the Baidu AI Cloud Smart Healthcare Partner Alliance, Weiming Penguin was selected alongside KPMG, INESA Xinnuo Shidai, Xunzheng Pharmaceutical, Quanzhen Medicine, FOSUN, HBIS Digital, and others. Dr. Zou Xiaoliang joined these industry guests in witnessing the alliance’s establishment, marking a new stage in ecosystem collaboration for the healthcare AI industry. As a core participant in the alliance, Weiming Penguin will work with Baidu AI Cloud and industry partners to advance the deployment of healthcare large-model technologies and reshape industry value.Exhibitions and Products — A New Vision for AI in the Healthcare IndustryThe conference exhibition area also presented a comprehensive range of innovations in healthcare, government services, smart hardware, and other fields. Weiming Penguin’s technological expertise and solutions in AI-powered healthcare digitalization closely complemented Baidu AI Cloud’s smart healthcare products, together outlining a new vision for AI in the healthcare industry.As a leader in AI-powered digital transformation for the pharmaceutical industry, Weiming Penguin has consistently driven industry change through technological innovation. By participating in this high-profile industry event, Dr. Zou Xiaoliang demonstrated not only the company’s technological strength and practical capabilities in healthcare AI, but also Weiming Penguin’s central position in the industry ecosystem. Looking ahead, Weiming Penguin will continue to deepen its work on healthcare large-model applications and build a new AI healthcare ecosystem with industry partners.Visit the Weiming Penguin website (www.tenez.cn) and follow our official WeChat account (wmpenguin). To discuss solutions or partnerships, you can also contact us directly through our dedicated service hotline at 137-1791-5751 (staffed on business days from 9:00–18:00, with your needs communicated directly). Together, we can explore paths to AI-powered digital transformation for pharmaceutical companies.
